CONMED Corp. (CNMD): Broker Consensus Forecast

Brandmark of CONMED Corp (CNMD)

CONMED Corporation (CNMD) creates comprehensive operating room solutions, fostering deep physician loyalty to its integrated systems. Business efficiency is driven by professional management and transparent logistics under the supervision of independent directors. The current metric is 46.65. The price action shown below confirms the company's status as a defensive asset, whose income remains independent of market volatility due to stable demand for medical technologies.

CNMD CONMED Corp: Analyst Consensus Forecast in the range 07/04/2022 - 11/12/2026
Brand item of CONMED Inc.

For CONMED Corporation (CNMD), this indicator merges market expectations with the business's fundamental value. The average forecast benchmark from investment firms is calculated as the weighted average of target prices from current analyst reports. Growth in this metric confirms capitalization driven by operational efficiency. The instrument manufacturer's optimization of packaging and energy costs strengthens its ESG profile, supporting positive valuation dynamics. Investors should interpret this trend as a reduction in risk for long-term holding.

Competitors of CONMED Corporation

Consensus Target dexcom.com DXCM|Price Target Chart Penumbra PEN|NOVT: Broker Consensus Forecast|HAE - Price Target Chart|Inspire Medical Systems Inc (INSP) - Consensus Target|PRCT: Analyst Consensus Forecast|Broker Consensus Forecast PLSE|Consensus Target INMD|PMI (Picard Medical Corp) - Analyst Forecast Prices|Analyst Consensus Forecast SRDX|SENS (Senseonics Holdings Inc) - Fair Value Consensus|Analyst Consensus Forecast NPCE (NeuroPace, Inc.)|Tactile Systems Technology, Inc. (TCMD) - Average Forecast Price|SNWV - Price Target Chart|Fair Value Consensus OM (Outset Medical Inc)|ELMD: Analyst Consensus Forecast|LENSAR Inc (LNSR) - Analyst Consensus Forecast|Price Target Chart AVITA Medical, Inc.|Profound Medical Corporation - Forecast Levels Chart|Analyst Consensus Forecast BDMD|EDAP - Average Forecast Price|Apyx Medical Corporation - Consensus Target|Analyst Consensus Forecast IceCure Medical Ltd. ICCM|LUNG: Consensus Target|TELA Bio, Inc. - Analyst Forecast Prices|CTSO: Analyst Consensus Forecast|SRTS - Analyst Median Target|ZYXI (Zynex Inc) - Analyst Consensus Forecast|Consensus Target electroCore Medical (ECOR)|Consensus Target RBOT (Vicarious Surgical Inc.)|IINN (inspira-technologies.com) - Fair Value Consensus|Price Target Chart SeaStar Medical ICU|IRIX - Consensus Target|Intelligent Bio - Analyst Consensus Forecast|Average Forecast Price Beyond Air, Inc.|PFSA: Analyst Consensus Forecast|Broker Consensus Forecast SSKN|GCTK (GlucoTrack) - Analyst Consensus Forecast|NanoVibronix Inc. (NAOV) - Analyst Median Target|Analyst Consensus Forecast VERO|Consensus Target Nuwellis Corp NUWE|Analyst Consensus Forecast AEMD (Aethlon Medical)|Analyst Consensus Forecast Asensus Surgical Inc ASXC|AVGR - Price Target Chart|BSGM: Price Target Chart|CUTR (Cutera, Inc) - Consensus Target|Know Labs Corporation - Fair Value Consensus|NARI (Inari Medical, Inc.) - Analyst Consensus Forecast|Average Forecast Price nevro.com NVRO|Price Target Chart ReShape Lifesciences (RSLS)|Silk Road Medical, Inc. (SILK) - Analyst Target Range